The clinical effectiveness of mistletoe extracts in cancer has been investigated in a great number of studies and clinical trials, primarily in Europe. A clinical trial is currently being conducted in the US at Johns Hopkins School of Medicine.
More information can be found within the following links:
Links to the four main producers of European mistletoe:
Helixor (only currently available in German)
WALA (producer of Iscusin)Abnoba
Licensed medical prescribers seeking more information and training in the use of mistletoe are encouraged to explore the PAAM Training Webinar Series: Mistletoe Use in Cancer Therapy, to subscribe to our Education Calendar in order to remain informed on upcoming courses and trainings in mistletoe therapy best practices, and to request more information by completing the web form below.
Patients seeking a physician trained in mistletoe therapy should visit the Patient Resources page.
Additional materials, information and clinical guidelines regarding mistletoe are provided to currently-licensed prescribers only, via a password-protected link to a private web page. All requests for materials are vetted before being issued a password and web address. Please provide the requested information and press the "Subscribe" button at the bottom. We will respond via email to your request with 14 days. Failure to provide information in any of the boxes below may result in a prolonged delay in granting your request.